Oct 14, 2026
ManyPress

Advertisement

Fashion

Facial bar Silver Mirror has introduced a new treatment called GLP-1 Volmira, designed to address skin concerns associated with rapid weight loss.

ManyPress

ManyPress

ManyPress Editorial

2 min readSource:WWD
Silver Mirror Launches GLP-1 Volmira Facial Treatment

Key facts

  • •The GLP-1 Volmira facial is a seven-step, needle-free treatment.
  • •The service is available at 10 Silver Mirror locations across New York, Miami, and Washington, D.C.
  • •Individual sessions cost $299, while a membership is priced at $239 per month.
  • •Silver Mirror recommends a six-month cycle of treatments to maintain skin health.
  • •Research from the Gallup National Health and Well-Being Index shows 11 percent of U.S. adults now use GLP-1 medications for weight loss.

Silver Mirror has launched a seven-step facial treatment named GLP-1 Volmira, aimed at addressing reports that skin may appear less full or firm during rapid weight loss. The treatment is available at all 10 of the company's studios located in New York, Miami, and Washington, D.C. Silver Mirror cofounder Matt Maroone stated that the service is not a medical procedure but is intended to provide consistent, expert care for skin during significant life changes.

By the numbers

$299
price per individual facial visit
$239
monthly cost for Volmira membership
11 percent
percentage of U.S. adults taking GLP-1s in 2026
3 percent
percentage of U.S. adults taking GLP-1s in 2024

Treatment Details and Pricing

The GLP-1 Volmira facial consists of seven steps: a cleanse, a needle-free biostimulating application, lifting, nano-infusion with a no-puncture tip, a cold biocellulose mask, LED therapy, and the application of finishing serums and SPF. The service is priced at $299 per visit, with a membership option available for $239 per month. The company recommends a cycle consisting of three monthly visits followed by three months of complementary facials.

Industry Context

According to Silver Mirror, the development of the facial was driven by guest interest and the executive team's personal experiences with GLP-1 medications. Cofounder Matt Maroone noted that search volume for 'Ozempic face' reaches 135,000 per month. Data from the Gallup National Health and Well-Being Index indicates that the percentage of U.S. adults taking GLP-1 medications for weight loss rose from 3 percent in 2024 to 11 percent in 2026.

Advertisement

This article was independently rewritten by ManyPress editorial AI from reporting originally published by WWD.

Fashion